Medical Device | October 06, 2021
Boston Scientific to acquire Baylis Medical Company for US $ 1.75 billion
The transaction is anticipated to close in the first quarter of 2022
The transaction is anticipated to close in the first quarter of 2022
The NanoDrop Eight simultaneously evaluates eight samples in 20 seconds or less and the instrument can also measure high-concentration samples of up to 200 absorbance units without dilution
It approves tissue-based NGS companion diagnostic for Takeda's targeted therapy for NSCLC patients with EGFR Exon20 insertion mutations
High-resolution image-based ART workflow software uses artificial intelligence to provide objective embryo grading, to assist embryologists during embryo selection
Formulation business grew by 15 per cent in the quarter
The company has already embarked upon significant expansion in Turkey
Initiative aims to strengthen South-South collaboration and capacity building in biomedical research
The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
Subscribe To Our Newsletter & Stay Updated
